| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,407 |
3,885 |
$406K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,103 |
4,626 |
$278K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,183 |
2,479 |
$100K |
| 99177 |
|
1,890 |
1,886 |
$64K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
763 |
763 |
$63K |
| 92587 |
|
2,009 |
1,994 |
$62K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
647 |
646 |
$54K |
| 99188 |
|
1,700 |
1,697 |
$44K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
435 |
435 |
$40K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,424 |
3,390 |
$32K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
352 |
330 |
$28K |
| 90461 |
|
957 |
954 |
$27K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,881 |
1,821 |
$20K |
| 96127 |
|
1,751 |
1,716 |
$20K |
| 99401 |
|
450 |
448 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
619 |
582 |
$7K |
| 81002 |
|
2,165 |
2,130 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
330 |
303 |
$5K |
| 94664 |
|
334 |
300 |
$5K |
| 96160 |
|
1,122 |
1,111 |
$4K |
| 94760 |
|
1,755 |
1,508 |
$4K |
| 99051 |
|
221 |
213 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
176 |
176 |
$4K |
| 92567 |
|
242 |
227 |
$3K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
353 |
323 |
$3K |
| 88738 |
|
453 |
446 |
$2K |
| 0071A |
|
43 |
43 |
$2K |
| 94761 |
|
293 |
272 |
$1K |
| 83655 |
|
82 |
81 |
$996.82 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
30 |
29 |
$946.52 |
| 36416 |
|
95 |
95 |
$712.50 |
| 0072A |
|
15 |
15 |
$688.20 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27 |
27 |
$633.51 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
251 |
230 |
$615.67 |
| 0051A |
|
12 |
12 |
$432.00 |
| 99173 |
|
18 |
18 |
$399.96 |
| 85018 |
|
151 |
151 |
$352.60 |
| 99070 |
|
29 |
26 |
$72.50 |